All Posts
Atenolol induced HDL-C change in the pharmacogenomic evaluation of antihypertensive responses (PEAR) study.
Published: February 27th, 2015
Hypertension susceptibility loci and blood pressure response to antihypertensives: results from the pharmacogenomic evaluation of antihypertensive responses study.
Published: February 27th, 2015
Pharmacogenomics of antihypertensive drugs: rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study.
Published: February 27th, 2015
Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.
Published: February 27th, 2015
Progress report on the Nordic diltiazem study (NORDIL): an outcome study in hypertensive patients.
Published: February 27th, 2015
The Nordic Diltiazem Study (NORDIL). A prospective intervention trial of calcium antagonist therapy in hypertension.
Published: February 27th, 2015
[Orthopedics at the cross-road?].
Published: February 27th, 2015
[Glycoside poisoning in experimental heart failure and its drug correction].
Published: February 27th, 2015
Ganglioside biosynthesis in rat liver. Characterization of three sialyltransferases.
Published: February 27th, 2015